Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan, Guangdong, 523808, China.
School of Pharmacy, Guangdong Medical University, Dongguan, Guangdong, 523808, China.
Sci Rep. 2017 Apr 26;7(1):1207. doi: 10.1038/s41598-017-01345-8.
Recently, numerous genome wide association studies (GWAS) and other case-control association studies examining the relationship between interleukin-7 receptor α chain (IL7RA) gene rs3194051, rs987107, rs11567686, and rs11567685 variants and multiple sclerosis (MS) risk have been conducted, but the conclusions have been inconsistent. The main objective of this meta-analysis was to more precisely explore the association of these four IL7RA variants with MS development. Twenty-seven eligible studies involving 9734 cases and 10436 controls were included in the present meta-analysis. Power calculation, publication bias, sensitivity analysis and cumulative meta-analysis were performed to derive a reliable conclusion. Our study indicated three IL7RA loci were significantly associated with increasing MS risk (rs3194051: recessive model: OR = 1.22, 95% CI 1.08-1.38; rs987107: recessive model: OR = 1.44, 95% CI 1.22-1.69; and rs11567686: dominant model: OR = 1.18, 95% CI 1.01-1.37). Additionally, IL7RA rs11567685 variants might not be related to MS development. In all, IL7RA locus polymorphisms could play an important role in the predisposition to MS, which could contribute to a better understanding the pathogenesis of multiple sclerosis.
最近,许多全基因组关联研究(GWAS)和其他病例对照关联研究都在研究白细胞介素 7 受体 α 链(IL7RA)基因 rs3194051、rs987107、rs11567686 和 rs11567685 变体与多发性硬化症(MS)风险之间的关系,但结论并不一致。本荟萃分析的主要目的是更精确地探讨这四个 IL7RA 变体与 MS 发病的关系。本荟萃分析共纳入 27 项符合条件的研究,包括 9734 例病例和 10436 例对照。进行了功效计算、发表偏倚、敏感性分析和累积荟萃分析,以得出可靠的结论。我们的研究表明,三个 IL7RA 位点与 MS 风险增加显著相关(rs3194051:隐性模型:OR=1.22,95%CI 1.08-1.38;rs987107:隐性模型:OR=1.44,95%CI 1.22-1.69;rs11567686:显性模型:OR=1.18,95%CI 1.01-1.37)。此外,IL7RA rs11567685 变体与 MS 发病无关。总之,IL7RA 基因座多态性可能在 MS 的易感性中起重要作用,这有助于更好地理解多发性硬化症的发病机制。